Anti-inflammatory and safety profile of DuP 697, a novel orally effective prostaglandin synthesis inhibitor.
Authors:
- W GalbraithWGW Galbraith
- R J RomanRRR J Roman
- S B HaberSHS B Haber
- J S KerrJKJ S Kerr
- W K SchmidtWSW K Schmidt
- C SmithCSC Smith
- W E HewesWHW E Hewes
- N R AckermanNAN R Ackerman
- 1 July 1990
- journal article
- research article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 254 (1) , 180-187
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Acute renal effects of sulindac and indomethacin in chronic renal failureClinical Pharmacology & Therapeutics, 1985
- Effects of sulindac and indomethacin on renal prostaglandin synthesisClinical Pharmacology & Therapeutics, 1984
- Differential renal effects of cyclooxygenase inhibition in sodium-replete and sodium-deprived dogAmerican Journal of Physiology-Renal Physiology, 1980
- Microsomal prostaglandin biosynthesis of human kidney.Journal of Biological Chemistry, 1980
- Mechanism of action of novel anti-inflammatory drugs diflumidone and R-805Biochemical Pharmacology, 1977
- Use of Writhing Test for Evaluating Analgesic Activity of Narcotic AntagonistsExperimental Biology and Medicine, 1965
- A Method for Evaluating both Non-Narcotic and Narcotic AnalgesicsExperimental Biology and Medicine, 1957
- A METHOD FOR MEASUREMENT OF ANALGESIC ACTIVITY ON INFLAMED TISSUE1957
- Development of Arthritis, Periarthritis and Periostitis in Rats Given Adjuvants.Experimental Biology and Medicine, 1956
- USE OF MOVING AVERAGES AND INTERPOLATION TO ESTIMATE MEDIAN-EFFECTIVE DOSEMicrobiology and Molecular Biology Reviews, 1947